CD8A and melanoma: CD4+ cells after uptake OVA-pulsed DEXs could stimulate efficient antigen-specific CTL responses and long-term T CD8+ cell memory in immunized C57BL/6 mice against OVA-transfected melanoma cells expressing OVA challenge after three months of complete immunization (76).